+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Clinical Effects of the Nd:YAG Laser Operating in the Photodisruptive and Thermal Modes

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The clinical effects of the Nd:YAG laser operating in both the photodisruptive (Q-switched) and thermal (free-running, cw) modes are discussed, and their clinical applications investigated. Moreover, the physical background of the working modes is explored. When working in the photodisruptive and fundamental (TEM<sub>00</sub>) modes, it is possible to carry out delicate clinical tasks with minimally invasive effects. When the laser is being used in the multimode regime, tasks that are highly resistant to photodisruptive laser radiation can be undertaken. In the thermal mode, photocoagulation can be performed. Nd:YAG laser light (1,064 nm) has high optical tissue penetration and good hemostatic properties, particularly when it is being operated in the frequency-doubled mode (KTP laser).

          Related collections

          Most cited references 4

          • Record: found
          • Abstract: not found
          • Article: not found

          Plasma formation in water by picosecond and nanosecond Nd:YAG laser pulses. I. Optical breakdown at threshold and superthreshold irradiance

           D Theisen,  J. Noack,  K Nahen (1996)
            • Record: found
            • Abstract: not found
            • Article: not found

            Intraocular Nd:YAG laser surgery: laser-tissue interaction, damage range, and reduction of collateral effects

              • Record: found
              • Abstract: not found
              • Article: not found

              Plasma formation in water by picosecond and nanosecond Nd:YAG laser pulses. II. Transmission, scattering, and reflection

               A. Vogel,  K Nahen (1996)

                Author and article information

                S. Karger AG
                February 2003
                06 February 2003
                : 217
                : 1
                : 1-16
                Lindenhofspital, Bern, Switzerland
                68240 Ophthalmologica 2003;217:1–16
                © 2003 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 18, References: 45, Pages: 16


                Comment on this article